Article Text

Download PDFPDF
Dalbavancin is a novel antimicrobial against Gram-positive pathogens: clinical experience beyond labelled indications
  1. María Núñez-Núñez PharmD, MsC1,2,
  2. Inmaculada Casas-Hidalgo1,
  3. Ricardo García-Fumero3,
  4. Inmaculada Vallejo-Rodríguez1,
  5. Francisco Anguita-Santos2,
  6. José Hernández-Quero2,
  7. José Cabeza-Barrera1,
  8. Andrés Ruiz-Sancho2
  1. 1Department of Pharmacy, University Hospital San Cecilio, Granada, Andalucía, Spain
  2. 2Department of Infectious Diseases, University Hospital San Cecilio, Granada, Andalucía, Spain
  3. 3Department of Pharmacy, University Hospital Virgen de las Nieves, Granada, Andalucía, Spain
  1. Correspondence to María Núñez-Núñez PharmD and MsC, Unidad de Gestión Clínica Farmacia, University Hospital San Cecilio, Granada CP 18016, Spain; mnunez.pharm{at}gmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.